KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)

Medpace Holdings (MEDP) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $4.0 million as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Non-Current Deffered Revenue fell 81.14% year-over-year to $4.0 million, compared with a TTM value of $4.0 million through Sep 2018, down 81.14%, and an annual FY2017 reading of $11.5 million, changed N/A over the prior year.
  • Non-Current Deffered Revenue was $4.0 million for Q3 2018 at Medpace Holdings, down from $11.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $21.4 million in Q2 2017 and bottomed at $4.0 million in Q3 2018.